Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Pharmacokinetics-Pharmacodynamics (PK-PD) Profile, Effectiveness and Safety of ATM-AVI in Special PopulationsRelease Date:Research Inflammation & Immunology China Impact of Rapid Diagnostic Tests (RDTs) on Treatment Pattern and Outcomes in Patients with Carbapenem-Resistant (CR) PathogensRelease Date:Research Inflammation & Immunology China Global Request for Proposals – Pfizer Clostridioides difficile (C. difficile) Research CollaborationRelease Date:Call for Collaborator(s) Vaccines France, Germany Initiatives to Improve the Clinical Environment for Dermatologic Immunology, Inflammation, and Allergy CareRelease Date:Partner: The Japanese Society for Cutaneous Immunology and AllergyQuality Improvement Inflammation & Immunology Japan Real World, Long-term Efficacy Study of Ritlecitinib in Adult and Adolescent Patients with Severe Alopecia Areata in ChinaRelease Date:Research Inflammation & Immunology China Epidemiology and surveillance of Gram-negative infections caused by carbapenemase-producing organisms (CPOs) in the UKRelease Date:Research Internal Medicine United Kingdom Advancing Care for Patients with Advanced ALK+ Non-Small Cell Lung Cancer (NSCLC)Education Oncology All Quality Improvement Solutions for the Diagnosis and Management of Migraine and Headache DisordersQuality Improvement Internal Medicine Canada, USA Shared Decision Making in Hemophilia Patient CareRelease Date:Quality Improvement Rare Disease China Title Grant Type Focus Area Country Application Due Date Addressing Healthcare Disparities in the Recognition, Early Diagnosis and Treatment of Primary ImmunodeficienciesRelease Date:Education Hospital USA Knowledge Gaps in the Prevention of COVID-19 in EuropeRelease Date:Education Vaccines All Hemophilia: Improving Knowledge of Novel Hemophilia Therapies Amongst Multidisciplinary TeamsRelease Date:Education Rare Disease USA Optimizing Androgen Deprivation Therapy (ADT) in Advanced Prostate CancerEducation Oncology USA Quality of Care Initiative to Improve the Treatment of Advanced or Metastatic Bladder Cancer PatientsQuality Improvement Oncology USA Educational Projects for Healthcare Professionals to Promote Cancer Patient SupportRelease Date:Partner: Japan Society of Clinical OncologyEducation Oncology Japan Latin America Needs Assessment of Prostate CancerRelease Date:Education Oncology All Menopause and Mental HealthRelease Date:Education Internal Medicine USA Efforts to Promote an Environmental Improvement for Cancer Genomic MedicineRelease Date:Partner: Japan Society of Clinical OncologyEducation Oncology Japan Understanding of Biosimilars and Shared Decision Making including Financial Burden in Cancer TreatmentRelease Date:Education Oncology Japan Review and analysis of retrospective, local source, serotype distribution for invasive pneumococcal diseaseRelease Date:Research Vaccines Hong Kong, Indonesia, Malaysia, Philippines, Singapore, Taiwan, Thailand, Vietnam Addressing Diagnostic Challenges for Non-Alcoholic Steatohepatitis (NASH)Release Date:Education Internal Medicine All